DGDA: Use of antibiotics restricted for coronavirus treatment

  28 March 2020

DGDA Director General (DG) Maj Gen Md Mahbubur Rahman said this at a press conference in Dhaka on Monday morning.

At the press conference, Delta Pharma Ltd announced to provide 300,000 necessary medicines (tablets) to treat Covid-19 patients. The medicines include Hydroxychloroquine and Azithromycin.

The director general said 100,000 tablets can be used for 20,000 coronavirus affected patients.

Apart from Delta Pharma, other pharmaceutical companies are also ready to supply medicines, he added

Further reading: Dhaka Tribune
Author(s): Dhaka Tribune
Healthy Patients  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

Evotec

JSS University

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





Global Ambassador Network

Welcome at the AMR Insights Ambassador Network!

The AMR Insights Ambassador Network is a growing, distinctive group of professionals who stand out for their commitment, willingness to cooperate and open attitude to combat Antimicrobial resistance (AMR).

More information and free-of-charge registration
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!